“Treatment With Tralokinumab Improves Health-Related Quality of Life in Adult Patients With Moderate to Severe Atopic Dermatitis: Results from a Phase 2b, Randomised, Double-Blind, Placebo-Controlled Study”. SKIN The Journal of Cutaneous Medicine, vol. 2, Dec. 2018, p. S64, https://doi.org/10.25251/skin.2.supp.64.